Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner. Published April 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 credits
MOC types
ABS — Accredited CMEUp to 0.5 pointsABIM — Medical KnowledgeUp to 0.5 pointsABS — Self-AssessmentUp to 0.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Board review / self-assessment
- includes Microlearning
- includes On-demand / recorded video
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
-
ReleasedApr 4, 2026
-
Last day to claim creditApr 6, 2027 6 months left
-
Research to Practice Expert Second Opinion: Roles of Immunotherapy and Targeted Therapy in the Management of Advanced GE Cancers Microlearning Activity 3 | 2026 (Video Program)
-
Research to Practice Expert Second Opinion: Current and Future Roles of Immunotherapy and Targeted Therapy in the Management of Advanced GE Cancers | 2026 (Symposium Video Proceedings)
-
Research to Practice Expert Second Opinion: Investigators Discuss the Optimal Management of HER2-Positive Gastrointestinal Cancers Microlearning Activity 2 | 2026 (Video Program)
-
Clinical Care Options, LLC (dba Decera Clinical Education) Expert Think Tank: New Developments in Immunotherapy-Based Management of Gastric/GEJ Cancers Across the Disease Continuum
-
Physicians’ Education Resource From Data to Decisions: Applying the Latest Evidence for New Targeted Therapies in HER2-Positive Gastroesophageal Adenocarcinoma
-
Answers in CME Inc. (AiCME) Translating Trials to Treatment: Practical Strategies for Immunotherapy Integration in Limited Stage- and Extensive Stage-SCLC
